EFFECT OF MAVACAMTEN ON HEALTH STATUS IN CHINESE PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: RESULTS FROM THE EXPLORER-CN STUDY

被引：0
|
作者：
Tian, Zhuang [1 ]
Li, Liwen [1 ]
Li, Xiaoyan [1 ]
Wang, Jianan [1 ]
Zhang, Qing [1 ]
Li, Zhanquan [1 ]
Peng, Daoquan [1 ]
Yang, Ping [1 ]
Ma, Wei [1 ]
Wang, Fang [1 ]
Jin, Wei [1 ]
Cheng, Xiang [1 ]
Humphries, Michael John [1 ]
Wang, Luojun [1 ]
Fu, Yiqun [1 ]
Zhang, Shuyang [1 ]
机构：
[1] Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1284-132
引用
收藏
页码：494 / 494
页数：1
相关论文
共 50 条
  • [31] The Association of Echo Parameters With Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy. Insights From the Explorer-HCM Trial
    Arnold, Suzanne V.
    Gosch, Kensey
    Dolan, Chantal
    Fine, Jennifer T.
    Masri, Ahmad
    Saberi, Sara
    Wang, Andrew
    Elliott, Perry M.
    Hegde, Sheila
    Lam, Jenny
    Sehnert, Amy J.
    Bach, Richard
    Spertus, John A.
    CIRCULATION, 2022, 146
  • [32] EFFECTS OF MAVACAMTEN ON CIRCULATING BIOMARKERS IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE EXPLORER-HCM STUDY USING COMPREHENSIVE PROTEOMICS PROFILING
    Wang, Zhaoqing
    Anderson, Warren
    Sehnert, Amy
    Ho, Carolyn
    Olivotto, Iacopo
    He, Aiqing
    Yao, Chen
    Florea, Victoria
    Mohammad, Atif
    Van Haelst, Paul
    Schafer, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 355 - 355
  • [33] Mavacamten in adolescent patients with symptomatic obstructive hypertrophic cardiomyopathy: design of the Phase 3 SCOUT-HCM trial
    Rossano, Joseph
    Canter, Charles
    Wolf, Cordula
    Favatella, Nick
    Lockman, Jeff
    Puli, Shilpa
    Javidialsaadi, Atefeh
    Dyme, Joshua
    Crevar, Christina
    Mital, Seema
    CIRCULATION, 2024, 150
  • [34] OUR RESULTS OF ALCOHOL SEPTAL ABLATION IN SYMPTOMATIC PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Yavuzgil, O.
    Tuluce, K.
    Gurgun, C.
    Kultursay, H.
    Payzin, S.
    Hasdemir, C.
    Can, L. H.
    Turkoglu, C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S72 - S72
  • [35] REAL WORLD EXPERIENCE AND 24-WEEK OUTCOMES OF PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TREATED WITH MAVACAMTEN IN THE US
    Reza, Nosheen
    Dubey, Anandkumar
    Carattini, Thomas
    Marzolf, Amy B.
    Hornsby, Nicole
    de Feria, Alejandro
    Ferri, Leticia
    Owens, Anjali Tiku
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 656 - 656
  • [36] Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten
    Reza, Nosheen
    Dubey, Anandkumar
    Carattini, Thomas
    Marzolf, Amy
    Hornsby, Nicole
    de Feria, Alejandro
    Mahmud, Nadim
    Schuler, Patricia
    Owens, Anjali Tiku
    JACC-HEART FAILURE, 2024, 12 (06) : 1123 - 1125
  • [37] Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
    Olivotto, Iacopo
    Oreziak, Artur
    Barriales-Villa, Roberto
    Abraham, Theodore P.
    Masri, Ahmad
    Garcia-Pavia, Pablo
    Saberi, Sara
    Lakdawala, Neal K.
    Wheeler, Matthew T.
    Owens, Anjali
    Kubanek, Milos
    Wojakowski, Wojciech
    Jensen, Morten K.
    Gimeno-Blanes, Juan
    Afshar, Kia
    Myers, Jonathan
    Hegde, Sheila M.
    Solomon, Scott D.
    Sehnert, Amy J.
    Zhang, David
    Li, Wanying
    Bhattacharya, Mondira
    Edelberg, Jay M.
    Waldman, Cynthia Burstein
    Lester, Steven J.
    Wang, Andrew
    Ho, Carolyn Y.
    Jacoby, Daniel
    LANCET, 2020, 396 (10253): : 759 - 769
  • [38] Late Health Status of Patients Undergoing Myectomy for Obstructive Hypertrophic Cardiomyopathy
    Nguyen, Anita
    Schaff, Hartzell, V
    Ommen, Steve R.
    Gersh, Bernard J.
    Dearani, Joseph A.
    Geske, Jeffrey B.
    Lahr, Brian D.
    Nishimura, Rick A.
    ANNALS OF THORACIC SURGERY, 2021, 111 (06): : 1867 - 1875
  • [39] Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study
    Monda, Emanuele
    Lioncino, Michele
    Palmiero, Giuseppe
    Franco, Francesco
    Rubino, Marta
    Cirillo, Annapaola
    Verrillo, Federica
    Fusco, Adelaide
    Caiazza, Martina
    Mazzella, Marialuisa
    Moscarella, Elisabetta
    Dongiglio, Francesca
    Sepe, Joseph
    Pacileo, Giuseppe
    Calabro, Paolo
    Limongelli, Giuseppe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 354 : 22 - 28
  • [40] Septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: An analysis of the patients with dissatisfactory intervention results
    Faber, L
    Welge, D
    Ziemssen, P
    Seggewiss, H
    Fassbender, D
    Horstkotte, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 145A - 145A
12345